Asia-Pacific Respiratory Device Market Growth, Size, Share, Industry Report and Forecast 2019-2025

Asia-Pacific Respiratory Device Market is estimated to grow $10.5 billion in 2027 from $6.9 billion in 2020, growing at a CAGR of 6.1% during the forecast period (2021-2027). Asia-Pacific region is considered to be the most emerging market due to the significant growth of the healthcare system in Asia-Pacific countries, such as India, China, and South Korea. Asia-Pacific region is forecast to witness immense growth due to significant investment by government and major market players, favorable government policies, and a high patient base. Asia-Pacific region covers more than 60% of the global population, has a high prevalence of respiratory diseases, such as asthma and COPD. These factors are expected to drive the growth of the market in the near future. Increasing air pollution in India is also one of the major causes of the growth of the respiratory device market.

To Request a Sample of our Report on Asia-Pacific Respiratory Device Market: https://www.omrglobal.com/request-sample/asia-pacific-respiratory-device-market

Growing Demand for Respiratory Device Market

The Asia-Pacific respiratory devices market presents future opportunities for growth as the prevalence of respiratory diseases such as asthma and COPD in emerging economies such as India and China. In addition, the increasing geriatric population specially in Japan is another major reason for the growing market.

(Get 15% Discount on Buying this Report)
A full Report of Asia-Pacific Respiratory Device Market is Available at: https://www.omrglobal.com/industry-reports/asia-pacific-respiratory-device-market

Scope of the Asia-Pacific Respiratory Device Market

Market Coverage

• The market number available - 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered- By Product, By End-User
• Regions Covered- Asia-Pacific (India, China, Japan, and Rest of Asia-Pacific)
• Competitive Landscape- Cipla Ltd., Novartis AG, Mylan N.V., Koninklijke Philips N.V., BMC Medical Co., Ltd.

Recent Strategic Initiatives in the Asia-Pacific Respiratory Device Market

• In May 2018, the company acquired NightBalance for expanding its sleep & respiratory care portfolio. The acquisition enables Philips Healthcare to expand its position in the home care market. In May 2017, Philips acquired the US-based RespirTech which provides solutions for chronic respiratory conditions such as pulmonary disease and cystic fibrosis. The acquisition enables the company to expand respiratory care, especially COPD patients with bronchiectasis.
• In January 2018, Resmed introduced Mobi which is a portable oxygen concentrator (POC). In May 2017, Resmed launched AirTouch F20 full face mask with UltraSoft memory for comfortable therapy of the patients. In January 2017 the company got FDA approval for AirMini. It is one of the smallest CPAP machines. In November 2016 Company launched AirFit N20 and AirFit F20 CPAP Masks.

Asia-Pacific Respiratory Device Market -Segmentation

By Product

• Respiratory Therapeutic Devices
• Respiratory Positive Airway Pressure Devices
• Respiratory Mask
• Respiratory Ventilators
• Respiratory Oxygen Concentrators
• Respiratory Inhalers
• Respiratory Resuscitators
• Respiratory Nebulizers
• Respiratory Humidifiers
• Respiratory Nitric Oxide Delivery Units
• Respiratory Oxygen Hoods
• Respiratory Diagnostic and Monitoring Devices
• Respiratory Pulse Oximeters
• Respiratory Capnography
• Respiratory Gas Analyzers
• Respiratory Spirometers
• Respiratory Polysomnography (PSG) Devices
• Respiratory Peak Flow Meters
• Respiratory Consumables and Accessories
• Respiratory Tracheostomy Tubes
• Respiratory Nasal Cannulas
• Respiratory Disposable Mask
• Respiratory Disposable Resuscitators
• Respiratory Other Consumables and Accessories

By End-User

• Hospitals
• Home Care
• Other End-Users
Asia-Pacific Respiratory Device Market – Segment by Region

Asia-Pacific

• India
• China
• Japan
• Rest of Asia-Pacific

Company Profiles

• 3M Co.
• Acorda Therapeutics, Inc.
• Adamis Pharmaceuticals Corp.
• Adherium Ltd.
• Aradigm Corp.
• AstraZeneca PLC
• Beximo Pharmaceuticals Ltd.
• BMC Medical Co., Ltd.
• Boehringer Ingelheim International GmbH
• Cipla Ltd.
• GlaxoSmithKline PLC
• Koninklijke Philips N.V.
• MidasCare Pharmaceutical Pvt. Ltd.
• Mylan N.V.
• Novartis AG
• Omron Healthcare Inc.
• ResMed Corp.
• Sunovion Pharmaceuticals
• Teijin Pharma Ltd.
• Teva Pharmaceuticals Industries Ltd.

Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/asia-pacific-respiratory-device-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.